Healthtech funding in Q4 2020
European Healthtech startup funding raised during Q4 2020.
In Q4 2020, 147 European Healthtech companies closed 151 funding rounds and raised €1.6B in equity funding (excluding debt and grants), up 66.4% versus Q4 2019. Debt rounds added €12M. Switzerland led by capital raised, and Fountain Healthcare Partners was the most active investor. Data as of 20 Nov 2026.
Equity funding
€1.6B
+66.4% vs Q4 2019 · excl. debt & grants · +€12M debt
Funding rounds
151
+7.1% vs Q4 2019
Companies
147
Top country
Switzerland
Rank among sectors
#4
7.7% of sector funding
Debt financing
€12M
0.7% of total
Top-10 round share
39.8%
of disclosed capital
Rounds ≥ €100M
1
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, Q4 2020 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Oct | €776M | 60 |
| Nov | €545M | 51 |
| Dec | €322M | 40 |
Top countries
by € raisedHealthtech — top countries by capital, Q4 2020 — interactive chart.
Data table
| Healthtech — top countries by capital, Q4 2020 | |
|---|---|
| Switzerland | €400M |
| UK | €281M |
| Israel | €249M |
| Germany | €194M |
| France | €138M |
| Ireland | €61M |
| Denmark | €59M |
| Spain | €58M |
Stage mix
by € raisedHealthtech — stage mix, Q4 2020 — interactive chart.
Data table
| Healthtech — stage mix, Q4 2020 | |
|---|---|
| Other | €614M |
| Series C | €265M |
| Series A | €253M |
| Series D+ | €201M |
| Series B | €154M |
| Seed | €102M |
| Growth/Late | €25M |
| Debt | €12M |
| Crowdfunding | €5.9M |
| Grant | €4.6M |
| Pre-Seed | €4.5M |
| Early VC | €2.4M |
Top deals
largest disclosed rounds in Q4 2020| Company | Stage | Date | Amount |
|---|---|---|---|
| Atai Life Sciences | Series C | Nov 2020 | €105M |
| Sophia Genetics | Series D+ | Oct 2020 | €94M |
| Vectivbio | Other | Oct 2020 | €94M |
| Pharvaris | Series C | Nov 2020 | €67M |
| Achilles Therapeutics | Other | Nov 2020 | €59M |
| CatalYm | Seed | Nov 2020 | €50M |
| MinervaX | Series B | Dec 2020 | €47M |
| Augury | Series D+ | Oct 2020 | €47M |
| Spineart | Other | Oct 2020 | €46M |
| Sparingvision | Other | Oct 2020 | €45M |
| MitrAssist | Other | Dec 2020 | €42M |
| Protalix Biotherapeutics | Other | Dec 2020 | €36M |
| K Health | Series D+ | Nov 2020 | €35M |
| Priothera Limited | Series A | Oct 2020 | €30M |
| Min Doktor | Other | Nov 2020 | €27M |
Top investors
most active in Q4 2020, by deal count- Fountain Healthcare Partners3 deals
- Atlantic Labs2 deals
- CDP Venture Capital2 deals
- Draper Esprit2 deals
- Horizon 20202 deals
- JME Ventures2 deals
- Kurma Partners2 deals
- Passion Capital2 deals
- Pureos Bioventures2 deals
- Wellington Partners2 deals